Cure My Disease

Don't miss your cure!

 Log in / Sign up

Earthworm enzyme trial aims to ease long covid and chronic fatigue

NCT ID NCT06511050

Recruiting now Symptom relief Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a dietary supplement called lumbrokinase in 120 adults with Long Covid, post-treatment Lyme disease syndrome, or ME/CFS. Participants take the supplement daily for 6 weeks. The goal is to see if it improves overall health and quality of life, as measured by a simple health rating scale.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
lumbrokinase (a dietary supplement derived from earthworms)
What this could lead to
If it works, this could point toward a new way to ease symptoms and improve quality of life for people with these chronic fatigue conditions.
What could go wrong
This is an early pilot study with only 120 people, so results may not apply widely. The supplement may not work or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC FATIGUE SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

long COVID-19 Lyme disease myalgic encephalomeyelitis/chronic fatigue syndrome Post-Lyme Disease Syndrome post-treatment Lyme disease syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC FATIGUE SYNDROME LONG COVID MYALGIC ENCEPHALOMYELITIS POST-TREATMENT LYME DISEASE SYNDROME

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)

    RECRUITING

    New York, New York, 10029, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.